European Healthcare Expenditure on Immunisation Programmes by Country

The data on European Healthcare Expenditure on Immunisation Programmes by Country reveals significant discrepancies between nations. Germany leads overwhelmingly with an expenditure of 21.98 billion Euros in 2024, far surpassing Denmark’s 1.76 billion Euros and the Czech Republic’s 1.67 billion Euros. France and the United Kingdom follow with 1.35 and 1.11 billion Euros, respectively. The remaining countries exhibit lower expenditures, with Malta at the bottom with merely 0.00159 billion Euros. Notably, the expenditures in 2024 represent forecasted values, while the actual data extends up to 2023.

Year-on-year variations from 2023 show substantial increases, especially in Greece (104.32%), Denmark (103.45%), and the Czech Republic (98.83%). Switzerland, Latvia, and Finland also present significant rises, indicating expanding investments in immunization. On the contrary, the United Kingdom and Poland experienced marginal declines, highlighting possible budget reallocations or efficiency improvements. Over the longer term, the Compound Annual Growth Rate (CAGR) reveals varied trends across the countries, showcasing diverse policy emphases and economic conditions.

Looking ahead, a sustained increase in healthcare expenditure on immunisation programmes in several European countries is anticipated. Factors influencing this trend may include heightened awareness from recent pandemics, technological advancements in vaccine development, and changing demographic patterns requiring more extensive immunisation efforts. Watch for emerging policies, international collaborations, and potential funding shifts that could reshape this landscape.